Slingshot members are tracking this event:
Genmab/Novartis' Arzerra (Ofatumumab) as Maintenance Therapy for Relapsed chronic lymphocytic leukemia PDUFA target date set to January 21, 2016
Slingshot Insights Explained
Jan 19, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Pdufa, Arzerra, Oftamumab, Relapsed Chronic Lymphocytic Leukemia